Connect your AI

Alpha Cognition ACOG Effective Income Tax Rate Reconciliation Tax Credits Research

Effective Income Tax Rate Reconciliation Tax Credits Research at other companies

AbCellera Biologics Inc.ABCL

-3.4%—

Cato CorporationCATO

-2.2%-3.5pp

WhirlpoolWHR

4.1%—

ICF InternationalICFI

9.2%-1.6pp

Oruka Therapeutics, Inc.ORKA

-2%-0.6pp

Avanos MedicalAVNS

-2.3%-3.2pp

Segments

By geography

US0.3%—

Other financials

Income statement

Revenue$3.5M+20.7%

Gross profit$3.3M+12.7%

Operating income-$8.1M-138%

Net income-$6.5M-276%

EPS (diluted)-$0.32-191%

Balance sheet

Cash & equivalents$54.3M+100,638%

Total equity$57.5M+49.2%

Total assets$69.2M+42.5%

Cash flow

Operating cash flow-$11.8M-477%

CapEx$1.3K-97.9%

Free cash flow-$11.8M-460%

Valuation

Market cap$157.21M+6.6%

P/S14.5×—

Profitability

Gross margin89.3%—

Operating margin-250.1%—

Net margin-232.2%—

FCF margin-280.5%—

Returns & leverage

Return on equity-52.4%-5.3pp

Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch.

The official record: Alpha Cognition’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's effective income tax rate reconciliation tax credits research.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Alpha Cognition's effective income tax rate reconciliation tax credits research?: Alpha Cognition (ACOG) reported effective income tax rate reconciliation tax credits research of 6.7% in Q4 2024.
What does effective income tax rate reconciliation tax credits research mean?: The reduction in tax liability resulting from specific research and development tax credits claimed by the company. This metric is critical for biopharmaceutical companies as it quantifies the government's support for innovation and R&D investment.